Year archive

RADIOPHARM THERANOSTICS LIMITED — 2026 filings

All 15 regulatory filings released by RADIOPHARM THERANOSTICS LIMITED (RAD) in 2026, sourced directly from the official regulator.

15 Filings

2026 Period

2026 filings (15)

Filing	Released	Lang
Financial Services and Company Secretary Changes 2 pages 275.7KB Regulatory Filings	2026-04-30	English
Quarterly Activities/Appendix 4C Cash Flow Report 12 pages 1.5MB Interim / Quarterly Report Q3 2026	2026-04-22	English
RAD Initial Findings from Phase 1 177Lu-RAD202 Trial 3 pages 136.7KB Regulatory Filings	2026-04-19	English
RAD Completes Enrollment in Phase 2b Trial of RAD 101 2 pages 355.3KB Regulatory Filings	2026-04-15	English
RAD202 Phase 1 HEAT Trial Advances to Dose Level 3 2 pages 131.9KB Capital/Financing Update	2026-04-07	English
RAD and Siemens Sign Clinical Supply Agreement for RAD101 2 pages 118.2KB Regulatory Filings	2026-04-06	English
Change of Director's Interest Notice (IT) 3 pages 241.4KB Director's Dealing	2026-03-30	English
RAD Doses First Patient in RAD 402 Phase 1 Clinical Study 2 pages 117.7KB Regulatory Filings	2026-03-26	English
RAD101 2nd interim Ph.2b data - 90% achieve primary endpoint 3 pages 142.8KB Capital/Financing Update	2026-03-23	English
RAD to present at NWR Virtual Healthcare Conference 2 pages 105.7KB Regulatory Filings	2026-03-18	English
Half Year Report and Appendix 4D 31 December 2025 30 pages 2.1MB Interim / Quarterly Report	2026-02-26	English
RAD Doses First Patient in 177Lu-BetaBart (RV-01) Study 2 pages 121.3KB Regulatory Filings	2026-02-23	English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 3.2MB Interim / Quarterly Report	2026-01-27	English
RAD Increases Ownership in Radiopharm Ventures to 87.5% 2 pages 117.1KB Capital/Financing Update	2026-01-11	English
Change in substantial holding 16 pages 6.9MB Regulatory Filings	2026-01-06	English